Adrenergic Drugs Flashcards
Alpha-1 pathway
Gq - PLC, IP3/DAG, Ca++/CaM, PKC, Ras, Raf, Mek, Erk
Beta/gamma subunit activity in Gq
PI-3 kinase, AKT
Alpha-2 pathway
Gi - Adenylyl cyclase inhibition, less cAMP, less PKA
Beta pathway
Gs - Adenylyl cyclase, cAMP, PKA (catalytic subunits)
Vascular smooth muscle
Alpha-1: Vasoconstriction
Beta-2: Vasodilation
Pupil
Alpha-1
Dilation
Hair
Alpha-1
Erects hair
Prostate
Alpha-1
Contraction
Heart
Alpha-1: Contraction
Beta-1: Contraction
Adrenergic and cholinergic nerve terminals (pre-synaptic)
Alpha-2: Inhibits transmitter release (auto-regulation)
Fat cells
Alpha-2: Inhibits lipid release
Beta-3: Activates lipid release
Smooth muscle (respiratory, uterine)
Beta-2: relaxation
Skeletal muscle
Beta-2: Potassium uptake
Liver
Beta-2: Glycogenolysis (activate glucose release)
Bladder
Beta-3: Relax detrusor
Renal blood vessels
D1: Dilation
Nerve endings
D2: Modulates transmitter release
Direct-acting adrenergic drug clases
Agonsts, antagonists
Indirect-acting adrenergic drug function
Altering NE at receptor location
Cocaine
Indirect agonist
Re-uptake inhibitor for DA and NE
Selegiline, Phenelzine
Indirect agonist
MAO inhibitors
Ephedrine
Mixed-acting agonist
NE release + receptor agonist
Amphetamines, Methylphenidate (Ritalin)
Indirect agonist
Reverse NE and DA uptake, increased release
Alpha direct agonist drugs
Phenylephrine
Methoxamine
Clonidine
Mixed alpha/beta direct agonist drugs
NE, Epinephrine
Beta direct agonist drugs
Dobutamine
Isoproterenol
Terbutaline
Albuterol
Dopamine direct agonist drugs
Dopamine
Fenoldopam
Alpha-1 > alpha-2 direct agonists
Phenylephrine
Methoxamine
Alpha-2 > alpha-1 direct agonists
Clonidine, methylnorepinephrine
NE vs Epinephrine
NE = Both alpha's, Beta-1 Epi = Both alpha's, both beta's
Beta-1 > beta-2 direct agonist
Dobutamine
Beta-2 > beta-1 direct agonists
Albuterol, terbutaline, ritodrine
Isoproterenol
Both beta’s equal
Fenoldopam
D1
Overall effect of an adrendergic drug is based on what things?
- Receptors expressed at a tissue
- Receptor selectivity of drug
- Intrinsic activity of drug
- Compensatory reflexes
- Tolerance and tachyphylaxis development
Tachyphylaxis
Sudden decrease in response to drug after administration
Drug tolerance
Progressively reduced response to drug over time
Epinephrine effects
- Increased heart fxn (beta-1)
- Constant arterial pressure (beta-2 + alpha-1)
- Bronchial relaxation (beta-2)
- Decreased bronchial secretion (alpha-1)
- Muscle tremor and hypokalemia (beta-2)
- Elevated blood glucose (beta-2 and alpha-2)
- Elevated blood FA’s (beta’s)
Norepinephrine effects
NOT beta-2…
- Increased heart fxn (beta-1)
- Vasoconstriction –> increased BP (alpha-1)
NE does NOT do what?
Bronchodilation or vasodilation
Dopamine effects at normal dose
- Renal, cerebral, mesenteric, coronary vasodilation (D1)
2. Suppressed NE release (D2)
Dopamine effect at higher doses
- Beta-1 activation in heart
4. Alpha-1 vasoconstriction
Phenylephrine effects
Alpha-1 direct agonist…
- Myadriasis (pupillary dilation) and decongestant
- Severe BP elevation (vasoconstriction)
Phenylephrine + baroreflex
HR sharp drop following BP elevation
Clonidine effects
Alpha-2 direct agonist (vasomotor center of brainstem)
- Decreased sympathetics (blocked NE release) a. Reduced BP (blocked NE = blocked alpha-1) b. Bradycardia (blocked NE = blocked beta-1)
Clonidine local application
Vasoconstriction????
Isoproterenol effects
Beta (both) direct agonist (inotropic, chronotropic)
- Increased cardiac output (beta-1) - Decreased BP (beta-2) - Bronchodilation (beta-2)
Dobutamine effects
Beta-1 agonist (inotropic)
- Increased heart contractility
Isoproterenol vs. dobutamine
Isoproterenol = MORE chonotropic action than dobutamine
Dobutamine and alpha-1
Given as racemic mixture of (+) isomer and (-) isomer, which antagonize alpha-1 and agonize alpha-1, respectively.
Outcome = no changed effect on alpha-1 receptors
Terbutaline effects
Beta-2 agonist
- Bronchodilation, uterine relaxation
Albuterol effects
Same as terbutaline
Selectivity of indirect-acting drugs
Non-selective, all receptors activated by the neurotransmitter are affected
Characteristics of indirect-acting agonist drugs
Lipophilic, penetrate BBB, CNS STIMULANTS
Function of indirect-acting agonists
Increase NE in cleft for signaling
Amphetamines
Increased NE in CNS…
- Alerting effects
- Improved attention
Cocaine
Inhibits transmitter re-uptake at adrenergic synapses
Ephedrine
Nonselective direct adrenergic agonist (like epinephrine)
Indirect increased release of transmitters (like amphetamines)
Mild CNS stimulant
Treating hypotensive emergencies
How?
NE, phenylephrine, methoxamine
Alpha-1 and alpha-2 antagonists
Phentolamine, phenoxybenzamine
Alpha-1 antagonists
Commonality?
Prazosin, Terazosin, Tamsulosin, Doxazosin, Alfuzosin, Silodosin
ALL END IN “-OSIN”
Phentolamine vs. phenoxybenzamine
Both alpha1 and alpha2 antagonists…
Phentolamine = competitive Phenoxybenzamine = irreversible non-competitive
Alpha antagonists on CV system
Decreased BP (peripheral)
Reflex tachycardia
Postural hypotension
Alpha antagonists on GU system
Prostate relaxation
Decreased resistance to urine flow
Alpha antagonists on eye
Pupillary constriction (dilator relaxation)
Alpha-1 selective vs. non-selective alpha antagonsits
Alpha-1 = decreased beta activity via alpha-2 activity Both = increased beta activity (increased heart fxn)
Atenolol, Betaxolol
Beta-1 antagonist
Nadolol, Propranolol
Beta antagonist
Acebutolol
Beta-1 partial agonist
Labetalol
Beta and alpha-1 partial agonist
Penbutolol, Pindolol
Beta partial agonist
Carvedilol
Beta and alpha-1 inverse agonist
Metoprolol
Beta-1 inverse agonist
Beta/beta-1 partial agonists are ______
Beta blockers with ISA (intrinsic sympathomimetic activity)
Partial agonists produce a ______
Benefit?
Used when?
Blunted sympathetic response
Less risk for bradycardia, increased cholesterol, or other beta receptor blockage issues
When full antagonist is not indicated (ex. lowering BP)
Beta-blockers on heart
Negative inotropic
Negative chronotropic
Block AV node (increased PR interval)
Beta-blockers on blood vessels
Initial rise in vascular resistance
Chronic - decrease in PVR due to heart effects
Beta-blockers on renal system
Inhibit renin release (decrease BP)
Beta-blockers on respiratory system
Increased airway resistance
Beta-blockers on eye
Reduced aqueous humor production –> lower intraocular pressure
Beta blockers on metabolism
Inhibit lypolysis
Increase LDL/HDL ratio (bad)
Inhibit glycogenolysis
Adverse effects of beta-blockers
Sedation/depression (CNS effects)
Bronchospasm/asthma attack (beta-2 blockers)
Hypotension
Increased VLDL, decreased HDL
Hypoglycemic episodes (post-prandial, DM type 1)
Blunted perception of hypoglycemic episodes
How to fix sedation/depression from beta-blockers
Switch to more hydrophilic drug
How to fix bronchospasm from beta-blockers
Switch to beta-1 selective
How to fix heart slowing from beta-blockers
Switch to partial agonist
How to fix VLDL increase from beta-blockers
Switch to partial agonist
How to fix hypoglycemic episodes from beta-blockers
Switch to beta-1 selective
Abrupt discontinuation of beta-blockers
Why?
Sympathetic hyper-response, heart problems
Body increases NE production to try to override beta-blocker, THUS will have extra after quitting drug
Guanethidine
Clinical use?
NE release inhibitor
Chronic HTN
Clonidine
Clinical use?
Presynaptic alpha-2 agonist
Chronic HTN
Metyrosine
Clinical use?
Tyrosine hydroxylase inhibitor (catecholamine production)
Pheochromocytoma
MoA of Guanethidine
NE release inhibitor…
Taken up by reuptake mechanism
Replaces NE in vesicles
Gradual depletion of NE stores